文献速递免疫规划传染病防控与疫情报告

常规实验室与健康行政数据评估流感疫苗效果的有效性:FOREVER队列研究

Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort.
PubMed 文献 · Vaccine · 2019-06-17

本研究通过链接呼吸道病毒实验室检测、住院、急诊和医生服务数据构建FOREVER队列,纳入2010-11至2015-16流感季54,434名65岁以上社区居民的65,648次检测。研究发现信息偏倚和选择偏倚有限,疫苗效果估计值范围从2010-11季的36%(95%CI 27-44%)到2014-15季的5%(95%CI -2-11%),与其他研究相当,表明常规数据可用于估计该人群的流感疫苗效果。

要点

  • 常规实验室与行政数据链接可用于估计社区老年人流感疫苗效果。
  • 6个流感季疫苗效果估计值范围36%至5%,与其他研究一致。
  • 需注意疫苗接种状态错分,敏感性分析校正后疫苗效果估计值更高。

核心结论

  • FOREVER队列中的常规实验室和健康行政数据可用于估计社区居住老年人的流感疫苗效果。

研究设计与样本

  • 研究链接个体水平的呼吸道病毒实验室检测、住院、急诊和医生服务数据构建FOREVER队列。
  • 纳入2010-11至2015-16流感季65岁以上社区居民的65,648次检测(来自54,434人)。

主要发现

  • 症状发作至采样间隔未知的患者流感阳性比例更接近间隔≤7天者而非>7天者。
  • 接种与未接种者接受流感检测的可能性相当,但部分医疗场所和流感季的调整比值比显著大于1。
  • 6个流感季疫苗效果估计值从2010-11季的36%(95%CI 27-44%)到2014-15季的5%(95%CI -2-11%)。
  • 通过定量敏感性分析校正疫苗接种状态错分后,疫苗效果估计值 consistently 更高。
  • FOREVER队列的疫苗效果估计值与其他研究相当。

临床怎么用

  • 可利用常规收集的实验室和行政数据开展低成本、大样本的流感疫苗效果评估。
  • 分析时需考虑疫苗接种状态错分的影响,可通过敏感性分析校正。

局限性

  • 使用便利样本可能引入选择偏倚,部分医疗场所和流感季接种者检测可能性更高。
  • 信息偏倚可能存在,但症状发作至采样间隔未知者的阳性比例与≤7天者更接近。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Linking data on laboratory specimens collected during clinical practice with health administrative data permits highly powered vaccine effectiveness (VE) studies to be conducted at relatively low cost, but bias from using convenience samples is a concern. We evaluated the validity of using such data for estimating VE. METHODS: We created the Flu and Other Respiratory Viruses Research (FOREVER) Cohort by linking individual-level data on respiratory virus laboratory tests, hospitalizations, emergency department visits, and physician services. For community-dwelling adults aged > 65 years, we assessed the presence and magnitude of information and selection biases, generated VE estimates under various conditions, and compared our VE estimates with those from other studies. RESULTS: We included 65,648 unique testing episodes obtained from 54,434 individuals during the 2010-11 to 2015-16 influenza seasons. To examine information bias, we found the proportion testing positive for influenza for patients with unknown interval from illness onset to specimen collection was more similar to patients for whom illness onset date was ≤ 7 days before specimen collection than to patients for whom illness onset was > 7 days before specimen collection. To assess the presence of selection bias, we found the likelihood of influenza testing was comparable between vaccinated and unvaccinated individuals, although the adjusted odds ratios were significantly greater than 1 for some healthcare settings and during some influenza seasons. Over 6 seasons, VE estimates ranged between 36% (95%CI, 27-44%) in 2010-11 and 5% (95%CI, -2, 11%) in 2014-15. VE estimates were similar under a range of conditions, but were consistently higher when accounting for misclassification of vaccination status through a quantitative sensitivity analysis. VE estimates from the FOREVER Cohort were comparable to those from other studies. CONCLUSIONS: Routinely collected laboratory and health administrative data contained in the FOREVER Cohort can be used to estimate influenza VE in community-dwelling older adults.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kwong JC, Buchan SA, Chung H, et al. Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort. Vaccine. 2019. PMID: 31221563. doi:10.1016/j.vaccine.2019.06.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。